174 related articles for article (PubMed ID: 36763222)
1. Predictors of future haemorrhage from cerebral cavernous malformations: a retrospective cohort study.
Gillespie CS; Alnaham KE; Richardson GE; Mustafa MA; Taweel BA; Islim AI; Hannan CJ; Chavredakis E
Neurosurg Rev; 2023 Feb; 46(1):52. PubMed ID: 36763222
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic Hemorrhage From Cerebral Cavernous Malformations: Evidence from a Cohort Study.
Gomez-Paz S; Maragkos GA; Salem MM; Ascanio LC; Lee M; Enriquez-Marulanda A; Orrego-Gonzalez E; Kicielinski K; Moore JM; Ogilvy CS; Thomas AJ
World Neurosurg; 2020 Mar; 135():e477-e487. PubMed ID: 31843731
[TBL] [Abstract][Full Text] [Related]
3. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation.
Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H;
J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309
[TBL] [Abstract][Full Text] [Related]
4. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis.
Zuurbier SM; Hickman CR; Tolias CS; Rinkel LA; Leyrer R; Flemming KD; Bervini D; Lanzino G; Wityk RJ; Schneble HM; Sure U; Al-Shahi Salman R;
Lancet Neurol; 2019 Oct; 18(10):935-941. PubMed ID: 31401075
[TBL] [Abstract][Full Text] [Related]
5. Natural history of brainstem cavernous malformations: prospective hemorrhage rate and adverse factors in a consecutive prospective cohort.
Li D; Wu ZY; Liu PP; Ma JP; Huo XL; Wang L; Zhang LW; Wu Z; Zhang JT
J Neurosurg; 2020 Mar; 134(3):917-928. PubMed ID: 32168479
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data.
Horne MA; Flemming KD; Su IC; Stapf C; Jeon JP; Li D; Maxwell SS; White P; Christianson TJ; Agid R; Cho WS; Oh CW; Wu Z; Zhang JT; Kim JE; Ter Brugge K; Willinsky R; Brown RD; Murray GD; Al-Shahi Salman R;
Lancet Neurol; 2016 Feb; 15(2):166-173. PubMed ID: 26654287
[TBL] [Abstract][Full Text] [Related]
7. Cerebral cavernous malformation: Management, outcomes, and surveillance strategies - A single centre retrospective cohort study.
Hill CS; Borg A; Horsfall HL; Al-Mohammad A; Grover P; Kitchen N
Clin Neurol Neurosurg; 2023 Feb; 225():107576. PubMed ID: 36608471
[TBL] [Abstract][Full Text] [Related]
8. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes.
Jaman E; Abdallah HM; Zhang X; Greene S
J Neurosurg Pediatr; 2023 Oct; 32(4):506-513. PubMed ID: 37503918
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation, natural history and outcomes of intramedullary spinal cord cavernous malformations.
Goyal A; Rinaldo L; Alkhataybeh R; Kerezoudis P; Alvi MA; Flemming KD; Williams L; Diehn F; Bydon M
J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):695-703. PubMed ID: 30760644
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhage from cerebral cavernous malformations: The role of associated developmental venous anomalies.
Chen B; Herten A; Saban D; Rauscher S; Radbruch A; Schmidt B; Zhu Y; Jabbarli R; Wrede KH; Kleinschnitz C; Sure U; Dammann P
Neurology; 2020 Jul; 95(1):e89-e96. PubMed ID: 32513786
[TBL] [Abstract][Full Text] [Related]
12. Morbidity After Symptomatic Hemorrhage of Cerebral Cavernous Malformation: A Nomogram Approach to Risk Assessment.
Ma L; Zhang S; Li Z; Wu CX; Wang Z; Zhan L; Hao Q; Wang H; Ye X; Chen X; Liu YO; Wang S; Zhao YL
Stroke; 2020 Oct; 51(10):2997-3006. PubMed ID: 32951540
[TBL] [Abstract][Full Text] [Related]
13. Solitary Sporadic Cerebral Cavernous Malformations: Risk Factors of First or Recurrent Symptomatic Hemorrhage and Associated Functional Impairment.
Dammann P; Jabbarli R; Wittek P; Oppong MD; Kneist A; Zhu Y; Wrede K; Müller O; Forsting M; Sure U
World Neurosurg; 2016 Jul; 91():73-80. PubMed ID: 27058610
[TBL] [Abstract][Full Text] [Related]
14. Gamma Knife® stereotactic radiosurgery for intracranial cavernous malformations.
Shanker MD; Webber R; Pinkham MB; Huo M; Olson S; Hall B; Jayalath R; Watkins T; Foote MC
J Clin Neurosci; 2022 Dec; 106():96-102. PubMed ID: 36274300
[TBL] [Abstract][Full Text] [Related]
15. Hemorrhage Risk of Untreated Isolated Cerebral Cavernous Malformations.
Kearns KN; Chen CJ; Yagmurlu K; Capek S; Buell TJ; Taylor DG; Pomeraniec IJ; Park MS; Kalani MY
World Neurosurg; 2019 Nov; 131():e557-e561. PubMed ID: 31400525
[TBL] [Abstract][Full Text] [Related]
16. Outcome after surgical or conservative management of cerebral cavernous malformations.
Moultrie F; Horne MA; Josephson CB; Hall JM; Counsell CE; Bhattacharya JJ; Papanastassiou V; Sellar RJ; Warlow CP; Murray GD; Al-Shahi Salman R;
Neurology; 2014 Aug; 83(7):582-9. PubMed ID: 24994841
[TBL] [Abstract][Full Text] [Related]
17. Neurological event prediction for patients with symptomatic cerebral cavernous malformation: the BLED2 score.
Orlev A; Feghali J; Kimchi G; Salomon M; Berkowitz S; Oxman L; Levitan I; Knoller N; Auriel E; Huang J; Tamargo RJ; Harnof S
J Neurosurg; 2022 Aug; 137(2):344-351. PubMed ID: 34920431
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcomes and natural history of intramedullary spinal cord cavernous malformations: a single-center series and meta-analysis of individual patient data: Clinic article.
Badhiwala JH; Farrokhyar F; Alhazzani W; Yarascavitch B; Aref M; Algird A; Murty N; Kachur E; Cenic A; Reddy K; Almenawer SA
J Neurosurg Spine; 2014 Oct; 21(4):662-76. PubMed ID: 25062285
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhage risks and functional outcomes of untreated brainstem cavernous malformations.
Li D; Hao SY; Jia GJ; Wu Z; Zhang LW; Zhang JT
J Neurosurg; 2014 Jul; 121(1):32-41. PubMed ID: 24785325
[TBL] [Abstract][Full Text] [Related]
20. Female Hormone Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations: A Multicenter Observational Cohort Study.
Zuurbier SM; Santos AN; Flemming KD; Schmidt B; Jabbarli R; Lanzino G; Sure U; Dammann P
Neurology; 2023 Apr; 100(16):e1673-e1679. PubMed ID: 36754635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
